Fibrocell science, inc. (FCSC)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue from product sales

-

-

337

270

170

200

153

-

936

Collaboration revenue

-

-

18

222

10

0

-

-

-

Total revenues

0

0

355

492

180

200

-

-

-

License fees

-

-

-

-

-

-

-

-

0

Total revenue

-

-

-

-

-

-

-

-

936

Cost of product sales

-

-

696

426

2,312

7,501

7,804

13

502

Cost of collaboration revenue

-

-

1

296

0

0

-

-

-

Total cost of revenue

-

-

697

722

2,312

7,501

-

-

-

Gross profit (loss)

-

-

-342

-230

-2,132

-7,301

-7,651

-13

433

Research and development expense

6,018

6,512

8,400

9,968

8,342

3,638

10,193

7,171

5,486

Selling, general and administrative expense

6,405

6,749

9,773

11,285

10,087

9,440

11,546

12,795

6,515

Total operating expenses

12,389

18,981

-

-

-

-

-

-

-

Intangible asset impairment expense

-

-

3,905

0

-

-

-

-

-

Restructuring costs

-

-

335

0

-

-

-

-

-

Operating income (loss)

-12,389

-18,981

-26,479

-37,407

-29,954

-30,503

-29,390

-19,979

-11,568

Other income (expense):
Warrant revaluation income

-

-

-

2,929

3,930

-1,053

-

-

-

Warrant revaluation income

921

4,920

11,884

-

-

-

-

-

-

Warrant revaluation and other finance income (expense)

-

-

-

-

-

-

20,404

2,562

-465

Derivative revaluation income (expense)

1,700

-1,407

-462

0

-

-

-23

-5,452

0

Interest expense

771

828

228

0

-

-

-

1,062

1,045

Reorganization items, net

-

-

-

-

-

-

-

-

-3

Other income (expense), net

-

-

-

25

-

-

-

-

244

Loss on extinguishment of debt

-

-

-

-

-

-

-5,617

-

-

Other income

-

-

-

-

368

0

0

-

-

Other income, net

300

56

-7

-

6

2

-1,017

-

-

Interest income

-

-

-

-

-

-

-

-

0

Income (loss) before income taxes

-10,277

-16,240

-15,292

-34,453

-25,650

-31,554

-

-23,931

-

Income tax benefit

0

0

0

0

0

0

-

-

0

Loss from continuing operations

-

-

-

-

-

-

-13,143

-

-12,830

Loss from discontinued operations, net of tax

-

-

-

-

-

-

-11

-94

-48

Gain on sale of discontinued operations, net of tax

-

-

-

-

-

-

467

-

-

Net Income (Loss) Attributable to Parent

-10,300

-16,240

-15,292

-34,453

-25,650

-31,554

-12,687

-24,025

-

Redeemable Preferred Stock Dividends

336

264

0

-

-

-

-

-

-

Preferred Stock, Deemed Dividend

513

4,099

0

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-12,879

Net loss attributable to non-controlling interest

-

-

-

-

-

-

24

18

51

Deemed dividend associated with beneficial conversion

-

-

-

-

-

-

-

-

0

Preferred stock dividends

-

-

-

-

-

-

-

-

0

Net income (loss) attributable to common stockholders

-11,126

-20,603

-15,292

-

-

-

-12,711

-24,043

-12,931

Loss from continuing operations before income taxes

-

-

-

-

-

-

-15,643

-23,931

-12,830

Deferred tax benefit

-

-

-

-

-

-

-2,500

-

-

Per Share Information:
Loss from continuing operations - basic

-

-

-

-

-

-

-1.47

-10.91

-

Loss from discontinued operations, net of tax - basic (in dollars per share)

-

-

-

-

-

-

-

-0.04

-

Gain on sale of discontinued operations, net of tax - basic

-

-

-

-

-

-

0.05

-

-

Net loss attributable to non-controlling interest, basic (in dollars per share)

-

-

-

-

-

-

-

-0.01

-

Earnings Per Share, Basic

-1.45

-6.66

-1.04

-0.82

-0.63

-1.06

-1.42

-10.96

-

Loss from continuing operations - diluted

-

-

-

-

-

-

-2.65

-10.99

-

Loss from discontinued operations, net of tax - diluted (in dollars per share)

-

-

-

-

-

-

-

-0.04

-

Gain on sale of discontinued operations, net of tax - diluted

-

-

-

-

-

-

0.05

-

-

Net loss attributable to non-controlling interest, diluted (in dollars per share)

-

-

-

-

-

-

-

-0.01

-

Earnings Per Share, Diluted

-1.45

-6.67

-1.18

-0.85

-0.70

-1.12

-2.60

-11.04

-

Loss from continuing operations - basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-0.68

Weighted average number of common shares outstanding:
Weighted Average Number of Shares Outstanding, Basic

7,693

3,092

14,641

42,178

40,789

29,830

8,965

2,194

-

Weighted Average Number of Shares Outstanding, Diluted

7,693

3,093

14,647

42,351

40,969

30,196

9,147

2,240

-

Loss from discontinued operations - basic and diluted

-

-

-

-

-

-

-

-

0.00

Deemed dividend associated with beneficial conversion of preferred stock

-

-

-

-

-

-

-

-

0.00

Preferred stock dividends

-

-

-

-

-

-

-

-

0.00

Net loss attributable to common shareholders per common share - basic and diluted

-

-

-

-

-

-

-

-

-0.68

Weighted average number of basic and diluted common shares outstanding

-

-

-

-

-

-

-

-

18,757

Affiliated Entity
Research and development expense

-34

5,720

-

-

-

-

-

-

-